Speaker illustration

Doctor Jean-Baptiste Guichard

Hospital Clinic of Barcelona, Barcelona (Spain)

Member of:

European Society of Cardiology
European Heart Rythm Association

After Studies of Medicine at University of Saint-Étienne, France, I did my residency in cardiology at University of Saint-Étienne, Department of Cardiology and Angiology from 2013 to 2019, followed by a fellowship in Cardiac Electrophysiology from 2019 to 2021. From 2016 to 2019, I integrated and managed a Ph.D. program in Biomedical Sciences, affiliated to University of Montreal, QC, Canada and University of Saint-Étienne, France. I defended my thesis named "Determinants of atrial remodeling and its pro-arrhythmic effect in atrial fibrillation" in 2019. Since 2019, I perform postdoctoral cardiovascular research both in terms of translational and clinical research, focused on cardiac electrophysiology in the laboratory SAINBIOSE, INSERM U1059, affiliated to University of Saint-Etienne. Since 2021 I am a clinic and research fellow at the Arrhythmia Section of Hospital Clínic and IDIBAPS, Universitat de Barcelona . Languages: French, Catalan, English, Spanish

Assessing heart rate fragmentation to predict atrial fibrillation in the general population aged 65

Event: EHRA 2024

Topic: Prevalence and Incidence of Atrial Fibrillation

Session: Atrial fibrillation: clinical 1

Thumbnail

Improving functional substrate delineation for ablation of ventricular tachycardia using high-density electroanatomic mapping and double ventricular extra stimuli protocol

Event: EHRA 2024

Topic: Ablation of Ventricular Arrhythmias

Session: Ventricular tachycardia 1

Thumbnail

Heart rate fragmentation as a marker of altered activity of the autonomic nervous system activity : a novel predictor of atrial fibrillation occurrence in the general population

Event: EHRA 2023

Topic: Prevalence and Incidence of Atrial Fibrillation

Session: ePoster session 46

Thumbnail

Predictors of atrial flutter recurrence after atrial fibrillation ablation: the crucial role of structural and morphological left atrial remodeling

Event: EHRA 2023

Topic: Rhythm Control, Catheter Ablation

Session: ePoster session 16

Thumbnail

Clinical markers of atrial abnormality as predictors of cardioembolic events in patients with embolic stroke of undetermined source.

Event: EHRA 2023

Topic: Mechanisms for Stroke

Session: Atrial Fibrillation - Round 2 - Stroke, ACO

Thumbnail

Heart rate fragmentation as a marker of altered global autonomic nervous system activity : a novel predictor of atrial fibrillation occurrence in the general population

Event: ESC Congress 2022

Topic: Atrial Stressors

Session: Insights in the pathophysiology of atrial fibrillation

Thumbnail

An N-/L-type calcium channel blocker, cilnidipine, reduces electrical and structural atrial remodeling associated with atrial fibrillation in a chronic dog model

Event: EHRA 2019

Topic: Arrhythmias

Session: Moderated ePosters 9: new basic arrhythmia insight from around the world

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb